Compare Stocks: BEAT, LUNG, MBOT, and ECOR

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BEAT HeartBeam	$0.43	$0.55	$0.40 ▼ $4.00	$24.05M	-0.8	455,438 shs	476,834 shs
ECOR electroCore	$9.21	$7.98	$4.41 ▼ $10.95	$83.07M	1	87,132 shs	19,955 shs
LUNG Pulmonx	$2.21	$1.82	$1.13 ▼ $2.89	$94.92M	0.34	481,685 shs	220,377 shs
MBOT Microbot Medical	$1.44	$1.71	$1.44 ▼ $4.67	$96.73M	1.03	794,572 shs	406,390 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BEAT HeartBeam	0.00%	-8.59%	-18.50%	-47.31%	-68.03%
ECOR electroCore	0.00%	-4.36%	+13.84%	-4.46%	+88.34%
LUNG Pulmonx	0.00%	-7.14%	+8.33%	+48.32%	+27.01%
MBOT Microbot Medical	0.00%	-2.70%	-23.81%	-20.88%	-60.66%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BEAT HeartBeam	$0.43	$0.55	$0.40 ▼ $4.00	$24.05M	-0.8	455,438 shs	476,834 shs
ECOR electroCore	$9.21	$7.98	$4.41 ▼ $10.95	$83.07M	1	87,132 shs	19,955 shs
LUNG Pulmonx	$2.21	$1.82	$1.13 ▼ $2.89	$94.92M	0.34	481,685 shs	220,377 shs
MBOT Microbot Medical	$1.44	$1.71	$1.44 ▼ $4.67	$96.73M	1.03	794,572 shs	406,390 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BEAT HeartBeam	0.00%	-8.59%	-18.50%	-47.31%	-68.03%
ECOR electroCore	0.00%	-4.36%	+13.84%	-4.46%	+88.34%
LUNG Pulmonx	0.00%	-7.14%	+8.33%	+48.32%	+27.01%
MBOT Microbot Medical	0.00%	-2.70%	-23.81%	-20.88%	-60.66%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BEAT HeartBeam	2.67	Moderate Buy	$4.00	837.21% Upside
ECOR electroCore	2.00	Hold	$18.00	95.44% Upside
LUNG Pulmonx	2.50	Moderate Buy	$7.67	246.91% Upside
MBOT Microbot Medical	2.40	Hold	$6.38	342.71% Upside

Current Analyst Ratings Breakdown

Latest BEAT, LUNG, MBOT, and ECOR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/25/2026	LUNG Pulmonx	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/20/2026	MBOT Microbot Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/19/2026	MBOT Microbot Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/14/2026	MBOT Microbot Medical	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$5.00 ➝ $4.00
7/22/2026	MBOT Microbot Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
7/14/2026	MBOT Microbot Medical	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
7/14/2026	BEAT HeartBeam	Maxim Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$2.00
7/13/2026	LUNG Pulmonx	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/8/2026	MBOT Microbot Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/2/2026	BEAT HeartBeam	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
6/24/2026	ECOR electroCore	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)

(Data available from 9/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BEAT HeartBeam	N/A	N/A	N/A	N/A	$0.06 per share	N/A
ECOR electroCore	$32.03M	2.59	N/A	N/A	($0.21) per share	-43.86
LUNG Pulmonx	$90.50M	1.05	N/A	N/A	$1.31 per share	1.69
MBOT Microbot Medical	N/A	N/A	N/A	N/A	$1.15 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BEAT HeartBeam	-$21.01M	-$0.51	N/A	N/A	N/A	N/A	-686.78%	-348.65%	11/12/2026 (Estimated)
ECOR electroCore	-$13.97M	-$1.66	N/A	N/A	N/A	-39.96%	-1,956.38%	-81.35%	11/4/2026 (Estimated)
LUNG Pulmonx	-$54M	-$1.16	N/A	N/A	N/A	-55.03%	-96.66%	-38.32%	11/11/2026 (Estimated)
MBOT Microbot Medical	-$13.14M	-$0.24	N/A	N/A	N/A	N/A	-21.87%	-20.76%	11/11/2026 (Estimated)

Latest BEAT, LUNG, MBOT, and ECOR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q2 2026	BEAT HeartBeam	-$0.0860	-$0.10	-$0.0140	-$0.10	$0.15 million	N/A
8/11/2026	Q2 2026	MBOT Microbot Medical	-$0.0767	-$0.08	-$0.0033	-$0.08	$0.13 million	$0.24 million
8/6/2026	Q2 2026	ECOR electroCore	-$0.4218	-$0.33	+$0.0918	-$0.33	$9.49 million	$9.45 million
7/29/2026	Q2 2026	LUNG Pulmonx	-$0.28	-$0.24	+$0.04	-$0.24	$22.39 million	$22.76 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BEAT HeartBeam	N/A	N/A	N/A	N/A	N/A
ECOR electroCore	N/A	N/A	N/A	N/A	N/A
LUNG Pulmonx	N/A	N/A	N/A	N/A	N/A
MBOT Microbot Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BEAT HeartBeam	N/A	3.66	3.61
ECOR electroCore	N/A	1.21	1.00
LUNG Pulmonx	0.95	4.32	3.52
MBOT Microbot Medical	N/A	18.56	17.82

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BEAT HeartBeam	7.77%
ECOR electroCore	26.74%
LUNG Pulmonx	91.04%
MBOT Microbot Medical	16.30%

Insider Ownership

Company	Insider Ownership
BEAT HeartBeam	17.95%
ECOR electroCore	7.80%
LUNG Pulmonx	7.50%
MBOT Microbot Medical	4.74%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BEAT HeartBeam	1,700	56.35 million	46.23 million	Not Optionable
ECOR electroCore	50	9.02 million	8.31 million	Not Optionable
LUNG Pulmonx	250	42.95 million	39.73 million	Optionable
MBOT Microbot Medical	20	67.17 million	63.98 million	Optionable

BEAT, LUNG, MBOT, and ECOR Headlines

Recent News About These Companies

Wall Street Zen Downgrades Microbot Medical (NASDAQ:MBOT) to Strong Sell

September 5 at 1:17 AM | marketbeat.com

Microbot Medical Inc. (NASDAQ:MBOT) Receives Average Rating of "Hold" from Analysts

August 29, 2026 | marketbeat.com

Microbot Medical (NASDAQ:MBOT) Lowered to "Hold" Rating by Zacks Research

August 22, 2026 | marketbeat.com

HC Wainwright Lowers Earnings Estimates for Microbot Medical

August 21, 2026 | marketbeat.com

B. Riley Financial Reaffirms "Buy" Rating for Microbot Medical (NASDAQ:MBOT)

August 14, 2026 | marketbeat.com

Microbot Medical Inc.: Microbot Medical Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter

August 11, 2026 | finanznachrichten.de

Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter

August 11, 2026 | markets.businessinsider.com

Microbot Medical Inc. (MBOT) Reports Q2 Loss, Lags Revenue Estimates

August 11, 2026 | zacks.com

Microbot Medical (NASDAQ:MBOT) Issues Earnings Results

August 11, 2026 | marketbeat.com

New Strong Buy Stocks for July 23rd

July 23, 2026 | zacks.com

Microbot Medical to Present on Endovascular Robotics at Society of Robotic Surgery Annual Meeting

July 21, 2026 | quiverquant.comQ

Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting

July 21, 2026 | globenewswire.com

Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026

July 7, 2026 | globenewswire.com

Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader

June 30, 2026 | globenewswire.com

Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System

June 25, 2026 | globenewswire.com

Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System

June 23, 2026 | globenewswire.com

Microbot Medical Expands Federal Access for LIBERTY Robotics

June 17, 2026 | theglobeandmail.com

Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations

June 16, 2026 | finance.yahoo.com

Microbot Medical® Enters Into an Agreement to Expand Access for America's Veteran and Military Patient Populations

June 16, 2026 | globenewswire.com

Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System

June 9, 2026 | globenewswire.com

Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System

June 2, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BEAT, LUNG, MBOT, and ECOR Company Descriptions

HeartBeam NASDAQ:BEAT

$0.43 0.00 (0.00%)

As of 09/4/2026 04:00 PM Eastern

BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in two segments, Healthcare and Research. The Healthcare segment focuses on the remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, memory loop event, and non-loop event monitors. It also provides traditional and extended Holter, pacemaker, international normalized ratio, implantable loop recorder, and other implantable cardiac device monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The company also focuses on manufacturing, testing, and marketing of cardiac devices and blood glucose monitoring devices, as well as offers contract manufacturing services. BioTelemetry, Inc. was founded in 1994 and is headquartered in Malvern, Pennsylvania.

electroCore NASDAQ:ECOR

$9.21 0.00 (0.00%)

As of 09/4/2026 04:00 PM Eastern

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Pulmonx NASDAQ:LUNG

$2.21 0.00 (0.00%)

As of 09/4/2026 04:00 PM Eastern

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Microbot Medical NASDAQ:MBOT

$1.44 0.00 (0.00%)

As of 09/4/2026 04:00 PM Eastern

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BEAT, LUNG, MBOT, and ECOR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BEAT, LUNG, MBOT, and ECOR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BEAT, LUNG, MBOT, and ECOR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BEAT, LUNG, MBOT, and ECOR Company Descriptions

HeartBeam NASDAQ:BEAT

electroCore NASDAQ:ECOR

Pulmonx NASDAQ:LUNG

Microbot Medical NASDAQ:MBOT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BEAT, LUNG, MBOT, and ECOR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BEAT, LUNG, MBOT, and ECOR Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BEAT, LUNG, MBOT, and ECOR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BEAT, LUNG, MBOT, and ECOR Company Descriptions

HeartBeam NASDAQ:BEAT

electroCore NASDAQ:ECOR

Pulmonx NASDAQ:LUNG

Microbot Medical NASDAQ:MBOT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools